Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
EDIT
Editas Medicine, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$2.57
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$394.70M
Country
USA
RECENT INSIDER TRADES
2026-09-04
· Parison Amy
(SVP, Chief Financial Officer)
· SELL
2026-09-04
· Burkly Linda
(EVP, CHIEF SCIENTIFIC OFFICER)
· SELL
2026-09-04
· O'Neill Gilmore Neil
(CEO)
· SELL
2026-08-05
· Parison Amy
(SVP, Chief Financial Officer)
· SELL
2026-07-29
· Burkly Linda
(EVP, CHIEF SCIENTIFIC OFFICER)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
235
Shares held
137,943,727
Value
$440.38M
Percent of shares outstanding
89.82%
As of quarter end
2026-06-30
RECENT NEWS
Editas Medicine cleared to start first-in-human trial of EDIT-401
Guggenheim upgrades Editas Medicine to higher rating
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Editas Medicine, Inc. (EDIT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit